Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats.
Zhang X, Zhao Y, Xu J, Xue Z, Zhang M, Pang X, Zhang X, Zhao L. · 2015
Read Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. by Zhang X, Zhao Y, Xu J, Xue Z, Zhang M, Pang X, Zhang X, Zhao L. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4585776.txt.
Description
Xu Zhang leads an eight-author team comparing two diabetes drugs through the gut, in Scientific Reports in 2015. Metformin is the world's standard type 2 diabetes drug, and berberine is a plant compound with similar effects. Both had recently been shown to work partly by reshaping gut microbes, which help drive obesity-linked metabolic disease.
In rats made obese on a high-fat diet, both drugs shifted the whole gut community back toward the lean pattern and cut its diversity. Of 134 microbe groups responding to treatment, 60 fell under both drugs. Groups that produce short chain fatty acids, a beneficial microbial output, rose markedly, more with berberine than metformin. The shared microbial signature tracked the animals' improved obese traits.
Catalog record
| CREATOR | Zhang X, Zhao Y, Xu J, Xue Z, Zhang M, Pang X, Zhang X, Zhao L. |
|---|---|
| YEAR | 2015 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |